Zoladex versus orchiectomy in treatmentof advanced prostate cancer: a randomized trial
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier BV in Urology
- Vol. 37 (1), 46-51
- https://doi.org/10.1016/0090-4295(91)80077-k
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinomaUrology, 1989
- Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.Journal of Clinical Oncology, 1987
- Zoladex (ICI 118,630): Clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinomaUrology, 1987
- Pre-Treatment Testosterone Levels: Significance in Androgen Deprivation TherapyJournal of Urology, 1986
- Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762Journal of Urology, 1986
- Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer.BMJ, 1985
- Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.BMJ, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Carcinoma of the prostate: Relationship of pretreatment hormone levels to survivalEuropean Journal of Cancer and Clinical Oncology, 1984
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941